目的探讨尿亮氨酸氨基肽酶(LAP)筛查糖尿病和高血压病早期肾损害的临床价值。
Objective To study the role of urine leucine aminopeptidase (LAP) for sifting early renal injury in diabetic and hypertension patients.
在激酶2中出现富含亮氨酸的突变，是基因相关的迟发型阿尔茨海默病的主要原因，在特定人群中影响大部分的阿尔茨海默病患者。
Mutations in the Leucine-rich repeat kinase 2 are the major cause of genetically-linked late onset Parkinson's affecting a high proportion of individuals with Parkinson's in certain populations.
应用推荐